Many of the general methods cross-referenced in Monograph 0478 (such as Dissolution 2.9.3 and Uniformity of Dosage Units 2.9.40) have undergone extensive harmonization. This reduces the burden on international manufacturers, allowing them to utilize streamlined testing protocols that satisfy multiple regulatory jurisdictions simultaneously.
Where disintegration confirms mechanical breakdown, dissolution testing measures the actual rate at which the active pharmaceutical ingredient (API) dissolves into a solution. Following modern policy updates by the EDQM Commission , an immediate-release solid dosage monograph requires a specific dissolution test to ensure in vivo bioequivalence and batch-to-batch consistency. 3. Uniformity of Dosage Units (Ph. Eur. 2.9.40) European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
The monograph emphasizes that the manufacturing process must ensure: Many of the general methods cross-referenced in Monograph
The monograph begins with a precise definition of what constitutes a "tablet." According to Ph. Eur. 0478, , obtained by compressing uniform volumes of particles or by another suitable manufacturing technique, such as extrusion, moulding or freeze-drying (lyophilisation). Following modern policy updates by the EDQM Commission